Medicines planning
47 results
Applied filters
NHMC Good Practice Principles for the Provision of Manufacturer Funded Homecare Services
5 March 2018Find attached the good practice principles for manufacturers offering manufacturer funded homecare medicine services
Have your say: biosimilars and patents resources
20 May 2026We are reviewing Specialist Pharmacy Service (SPS) resources on biosimilars and patents to ensure they meet the needs of NHS services.
Horizon scanning for ATMPs
13 June 2023Describes what horizon scanning is, how it is performed for the NHS and it's importance for ATMPs.
National Homecare Medicines Committee regional contacts
12 May 2025Contact details of the homecare regional specialists within the UK who sit on the National Homecare Medicines Committee (NHMC).
The licence and supporting evidence for omalizumab biosimilar
20 April 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences.
Preparing to use ustekinumab biosimilar
29 July 2025Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
Good governance when implementing ustekinumab biosimilar
29 July 2025Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.
The licence and supporting evidence for ustekinumab biosimilars
29 July 2025Ustekinumab biosimilars (Pyzchiva, Steqeyma, Uzpruvo, Wezenla) are licensed. Learn about indications, formulations, supporting evidence and differences.
The licence and supporting evidence for denosumab 120mg biosimilars
16 January 2026Denosumab 120mg biosimilars are licensed. Learn about indications, formulations, supporting evidence and differences.
The licence and supporting evidence for ranibizumab biosimilars
5 November 2025Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence